Human gene
ATP13A2 ATPase cation transporting 13A2
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 1552 | Neuronal ceroid lipofuscinosis, 12 | dog | ATP13A2 | one to one | Target evidence |
61.5
|
| 1552 | Neuronal ceroid lipofuscinosis, 12 | Rhesus monkey | ATP13A2 | one to one | Target evidence |
61.5
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| Kufor-Rakeb syndrome | MONDO:0011706 | 0.84 | 1,341 |
| autosomal recessive spastic paraplegia type 78 | MONDO:0014975 | 0.80 | 998 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.